EcoDrugPlus

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSCLMG00005014536
Gene Symbol: ADRM1
1 Cross references
195 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSCLMG00005015042
Gene Symbol: AKT1
1 Cross references
196 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSCLMG00005010397
Gene Symbol: APEX1
1 Cross references
214 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSCLMG00005003089
Gene Symbol: APH1B
1 Cross references
192 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSCLMG00005007029
Gene Symbol: ABCB1
1 Cross references
163 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 1

Ensembl ID : ENSCLMG00005015961
Gene Symbol: ABCC1
1 Cross references
203 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSCLMG00005023091
Gene Symbol: ABCC8
1 Cross references
227 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSCLMG00005012703
Gene Symbol: ABCC9
1 Cross references
233 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Alpha

Ensembl ID : ENSCLMG00005004899
Gene Symbol: ATP4A
1 Cross references
183 Possible Orthologues:

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSCLMG00005008219
Gene Symbol: ATP4B
1 Cross references
171 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 2

Ensembl ID : ENSCLMG00005003148
Gene Symbol: ATP1A1A.2
1 Cross references
270 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 1

Ensembl ID : ENSCLMG00005006063
Gene Symbol: ATP1B1
1 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).